Industry News
Swiss BCI startup ABILITY Neurotech wins Dutch regulatory approval to begin first chronic implantation of its fully implantable wireless BCI in ALS patients
ABILITY Neurotech, the Geneva-based Wyss Center spinout building Europe's first fully implantable wireless optical-link ECoG brain-computer interface, received Investigational Medical Device Dossier (IMDD) approval from MREC NedMec in the Netherlands on 26 May 2026 to begin the first chronic implantation study of its device in ALS patients at UMC Utrecht under the INTRECOM consortium.